Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 23 Dec 2024

The role of APOE gene polymorphisms in lung adenocarcinoma susceptibility and lipid profile

in Cancer Immunity and Immunotherapy

Huanhuan Bi
Dunqiang Ren
Ye Wang
Hongmei Wang
Chunling Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1522761

607 views

Original Research

Published on 23 Dec 2024

Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment

in Cancer Immunity and Immunotherapy

Victoria A. Jennings
Reah Rumbold-Hall
Gemma Migneco
Tyler Barr
Katrina Reilly
Nicola Ingram
Isabelle St Hilare
Samuel Heaton
Noura Alzamel
David Jackson

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500570

1,422 views

Case Report

Published on 23 Dec 2024

Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the literature

in Cancer Immunity and Immunotherapy

Jiaxiang Ji
Chin-Hui Lai
Xiaowei Zhang
Hao Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501415

788 views

Original Research

Published on 23 Dec 2024

Immune-related thyroid dysfunction as a positive prognostic factor for patients with lung cancer in China: a real-world retrospective study

in Cancer Immunity and Immunotherapy

Ge Guo
Zihan Jing
Wenrui Dou
Guiqin Wang
JunJie Dang
Yajie Li
Ruqiong Wang
Huan Zhang
Jing Sun
Lihua Shang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495460

588 views

Review

Published on 23 Dec 2024

From multi-omics to predictive biomarker: AI in tumor microenvironment

in Cancer Immunity and Immunotherapy

Luo Hai
Ziming Jiang
Haoxuan Zhang
Yingli Sun

Frontiers in Immunology

doi 10.3389/fimmu.2024.1514977

962 views

Original Research

Published on 23 Dec 2024

Effects of chemoradiotherapy on surface PD-L1 expression in esophageal cancer and its implications for immunotherapy

in Cancer Immunity and Immunotherapy

Lovis Hampe
Stefan Küffer
Tim Niemeier
Niklas Christian Scheele
Laetitia Zoe Hampe
Anna Luisa Riedl
Laura Anna Fischer
David Alexander Ziegler
Martin Leu
Leif Hendrik Dröge

Frontiers in Immunology

doi 10.3389/fimmu.2024.1509051

1,307 views

Systematic Review

Published on 23 Dec 2024

Efficacy and safety of immune checkpoint inhibitors for EGFR mutated non-small cell lung cancer: a network meta-analysis

in Cancer Immunity and Immunotherapy

Lin Zhu
Wenjuan He
Cunlei Xie
Yang Shu
Chunxia Zhang
Yawen Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1512468

1,295 views

Case Report

Published on 23 Dec 2024

Anlotinib combined with tislelizumab in the treatment of primary small cell neuroendocrine carcinoma of the prostate: a case report and literature review

in Cancer Immunity and Immunotherapy

Xin Fei
Zhong Zheng
Zhen-ya Zhao
Da-wei Ren
Su-ying Wang
Shi-jie Ye
Lin-chun Liang
Da Li
Xiao-long Jia
Qi Ma

Frontiers in Immunology

doi 10.3389/fimmu.2024.1510069

815 views

Case Report

Published on 23 Dec 2024

Efficacy of combined surgery and pembrolizumab for the treatment of pulmonary large cell carcinoma: a case report

in Cancer Immunity and Immunotherapy

Linguo Gu
Hongzuo Chen
Zhenkun Xia
Bei Qing
Yunchang Yuan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500996

571 views

Original Research

Published on 23 Dec 2024

SQLE-mediated squalene metabolism promotes tumor immune evasion in pancreatic cancer

in Cancer Immunity and Immunotherapy

Junchen Pan
Haixi Liang
Lin Zhou
Wenhua Lu
Bitao Huo
Rui Liu
Peng Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1512981

993 views

Review

Published on 23 Dec 2024

Mitochondria: a crucial factor in the progression and drug resistance of colorectal cancer

in Cancer Immunity and Immunotherapy

Ying Zhao
Xiaomin Guo
Li Zhang
Dongwei Wang
Yan Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1512469

962 views

Review

Accepted on 20 Dec 2024

Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy

in Cancer Immunity and Immunotherapy

Rongcun Yang
Yuqing Liu
Fan Li
Juanjuan Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1518779

146 views

Original Research

Published on 20 Dec 2024

Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer – implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils

in Cancer Immunity and Immunotherapy

Veronika Karlsson
Ebba Stål
Emma Stoopendahl
Anton Ivarsson
Hakon Leffler
Maria Lycke
Martina Sundqvist
Karin Sundfeldt
Karin Christenson
Elin Bernson

Frontiers in Immunology

doi 10.3389/fimmu.2024.1506236

907 views

Review

Published on 20 Dec 2024

N6-methyladenosine RNA methylation, a new hallmark of metabolic reprogramming in the immune microenvironment

in Cancer Immunity and Immunotherapy

Xiaoyue Li
Lin Peng
Xuelian Yang
Jing Luo
Jianmei Wang
Kelin Mou
Huan Zhou
Yuhao Luo
Li Xiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1464042

846 views

Original Research

Published on 20 Dec 2024

Targeting CEA in metastatic triple negative breast cancer with image-guided radiation followed by Fab-mediated chimeric antigen receptor (CAR) T-cell therapy

in Cancer Immunity and Immunotherapy

Eric Aniogo
Maciej Kujawski
Dennis Awuah
Seung E. Cha
Ruby Espinosa
Susanta Hui
Hemendra Ghimire
Paul J. Yazaki
Christine E. Brown
Xiuli Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1499471

1,351 views

Review

Published on 20 Dec 2024

The modulation of immune cell death in connection to microRNAs and natural products

in Cancer Immunity and Immunotherapy

Ya-Ting Chuang
Ching-Yu Yen
Jen-Yang Tang
Fang-Rong Chang
Yi-Hong Tsai
Kuo-Chuan Wu
Tsu-Ming Chien
Hsueh-Wei Chang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425602

971 views

Navigation group

Articles

The role of APOE gene polymorphisms in lung adenocarcinoma susceptibility and lipid profile

Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment

Immune-related adverse events with renal colic as the main manifestation: a case report of sintilimab-induced ureteritis/cystitis treated by ureteral stent and review of the literature

Immune-related thyroid dysfunction as a positive prognostic factor for patients with lung cancer in China: a real-world retrospective study

From multi-omics to predictive biomarker: AI in tumor microenvironment

Effects of chemoradiotherapy on surface PD-L1 expression in esophageal cancer and its implications for immunotherapy

Efficacy and safety of immune checkpoint inhibitors for EGFR mutated non-small cell lung cancer: a network meta-analysis

Anlotinib combined with tislelizumab in the treatment of primary small cell neuroendocrine carcinoma of the prostate: a case report and literature review

Efficacy of combined surgery and pembrolizumab for the treatment of pulmonary large cell carcinoma: a case report

SQLE-mediated squalene metabolism promotes tumor immune evasion in pancreatic cancer

Mitochondria: a crucial factor in the progression and drug resistance of colorectal cancer

Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy

Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer – implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils

N6-methyladenosine RNA methylation, a new hallmark of metabolic reprogramming in the immune microenvironment

Targeting CEA in metastatic triple negative breast cancer with image-guided radiation followed by Fab-mediated chimeric antigen receptor (CAR) T-cell therapy

The modulation of immune cell death in connection to microRNAs and natural products